Cardiac Rhythm Management (CRM) Devices Market to Surpass US$ 19,938.3 Mn by 2026, Boston Scientific Corporation and Medtronic Covers Majority of the Share: Fortune Business Insights

Key companies covered in the Cardiac Rhythm Management (CRM) Devices Market Research report include Physio Control, Cardiac Science, Medtronic, Stryker, CU Medical Systems Inc., Defibtech, LLC., Abbott, Boston Scientific Corporation, MicroPort, BIOTRONIK, and LivaNova PLC


Pune, July 01, 2019 (GLOBE NEWSWIRE) -- Technological advancements in cardiac rhythm devices are driving the global cardiac rhythm management devices market. Fortune Business Insights in a report, titled Cardiac Rhythm Management Devices Market: Global Market Analysis, Insights and Forecast, 2019-2026” projects the global market to register a CAGR of 4.4% between 2019 and 2026. In 2019, the global market was worth US$ 13,883.7 Mn and is anticipated to be worth US$ 19,938.3.1 Mn by 2026.  The rising prevalence of cardiovascular disorders across the world is the chief factor responsible for positively impacting the growth of the market.


Browse Complete Report Details with Table of Content and Figures:

https://www.fortunebusinessinsights.com/industry-reports/cardiac-rhythm-management-devices-market-100679


Defibrillators Register Strong Growth Than Other Products

Among different products, the market will witness strong demand for defibrillators in the global market during the forecast period. In 2018, they covered a share of 49.0% in the global cardiac rhythm management devices market. These are generally used to treat out-of-hospital cardiac arrests and arrhythmia. Under defibrillators, implantable cardioverter defibrillator (ICD) are preferred over external defibrillators. Moreover, physicians also recommend this type of defibrillator as they have the ability to effectively deliver electric shocks for the restoration of a heartbeat. On the other hand, the installation of the external defibrillator is increasing in developed and developing nations with the growing incidence of out-of-hospital cardiac arrests. Governments in some countries have passed a mandate to install external defibrillators at public places. The objective is to have easy access to cardiac patients.

North America Dominates Owing to Favorable Healthcare Reimbursement Policies

From a geographical standpoint, North America is anticipated to dominate the global cardiac rhythm management devices market in the forecast years. Well-established healthcare infrastructure and favourable healthcare reimbursement policies are contributing to the growth of the market. The market in this region was valued at US$ 5,914.1 Mn in the year 2018. Cardiac patients have shifted their focus to preventive care. This rising shift is fueling demand for cardiac rhythm management devices. In addition to this, governments have made strict guidelines to install external defibrillators, especially in public places. Against this backdrop, the demand for cardiac rhythm management devices is increasing, which will in due course, drive the market.

The market in Asia Pacific is expected to grow considerably during the forecast years. This is mainly attributable to the rising penetration of health insurance across developing countries. 


Sample PDF https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cardiac-rhythm-management-devices-market-100679


Increasing Awareness About Cardiac Management Devices Propels Growth in the Market

“Several developing economies are witnessing massive demand for implantable cardiac rhythm devices owing to the rising awareness about different products among the population,” said a lead analyst at Fortune Business Insights. “This, coupled with rising disposable income, act as potential growth enablers in the market,” he added. As per a study conducted by the European Cardiac Society, it was found that certain Western European countries registered an implantation rate of over 1000 units per million populations.  The increasing adoption of implants especially in emerged countries represents a rising preference of cardiac rhythm management devices amongst the population.

The rapid adoption of a sedentary lifestyle among the population can lead to increasing number of cardiac arrests, which in turn, is another factor driving the market.

Among end-users, the demand for cardiac monitoring devices is likely to increase across hospitals, clinics, ambulatory surgery centers and others.

Medtronic Tops Among Other Companies Owing to its Robust Product Portfolio

Physio Control, Cardiac Science, Medtronic, Stryker, CU Medical Systems Inc., Defibtech, LLC., Abbott, Boston Scientific Corporation, MicroPort, BIOTRONIK, and LivaNova PLC are some of the leading players operating in the global cardiac rhythm management devices market. Among these companies, Medtronic is leading the global implantable cardioverter defibrillator market and accounts for a major share in the global pacemaker market. The wide array of product offerings and their availability are factors responsible for the company’s leading position. These factors, together with the company’s strong customer base, will help the company to emerge dominant during the forecast period. Medtronic together with Boston Scientific Corporation currently holds over half of the share in the global market.

Key Companies Mentioned

  • Medtronic
  • Boston Scientific Corporation
  • Biotronik
  • Asahi Kasei Corporation
  • Philips Healthcare
  • Defibtech, LLC.
  • Cardiac Science
  • Stryker
  • CU Medical System Inc.
  • LivaNova Plc
  • Abbott
  • Microport
  • Other prominent players



Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/cardiac-rhythm-management-devices-market-100679



Table of Content:

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Technological Advancements in Cardiac Rhythm Management Devices
    • New Product Launches by Key Players
    • Regulatory Scenario for Key Countries

  • Global Cardiac Rhythm Management Devices Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary

    • Market Analysis, Insights and Forecast – By Product
      • Cardiac Pacemakers
        • Single Chamber Cardiac Pacemaker
        • Dual Chamber Cardiac Pacemaker
      • Defibrillators
        • Implantable Cardioverter Defibrillators (ICD)
          • Single Chamber ICD
          • Dual Chamber ICD
      • External Defibrillators
        • Automated External Defibrillators
        • Manual & Semi-Automatic External Defibrillators
        • Wearable Defibrillators

    • Cardiac Re-Synchronization Therapy (CRT)Devices
      • CRT- Pacemakers
      • CRT-Defibrillators

    • Market Analysis, Insights and Forecast – By End User
      • Hospitals & Clinics
      • Ambulatory Surgery Centers and Others

    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia pacific
      • Rest of the World
  •  Competitive Analysis   
  • Strategic Recommendations    



Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/cardiac-rhythm-management-devices-market-100679


Browse Related Reports:

  • Cardiac Pacemakers Market Size, Share and Global Trend by Product (Single Chamber Pacemakers, Dual Chamber Pacemakers, Cardiac Resynchronization Therapy-Pacemakers (CRT-P)), By End User (Hospitals & Clinics, Ambulatory Surgery Centers and Others) & Geography Forecast till 2026
  • Immunodiagnostics Market Size, Share and Global Trend by Product Instruments, Reagents & Consumables), By Application (Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases), By End user (Clinical Laboratories, Hospitals, Physician’s Offices), By End-user (Hospitals, Dental Clinics, Academic & Research Institutes) and Geography Forecast till 2026
  • Parkinson’s Disease Drugs Market Size, Share and Global Trend By Drug Class (Decarboxylase Inhibitors, Dopamine Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitors), Route of Administration (Oral, Injection, Transdermal), Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) & Geography Forecast till 2026
  • Intravenous Immunoglobulins Market Size, Share and Global Trend By Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Geography Forecast till 2025

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. 

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact us:

Fortune Business Insights Pvt. Ltd. 
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
US :+1-424-253-0390
UK :+44-2071-939123
APAC :+91-744-740-1245
Email: sales@fortunebusinessinsights.com 
Website: https://www.fortunebusinessinsights.com

Attachment

CARDIAC-RHYTHM-MANAGEMENT-DEVICES